Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
KDEV.STthis companyKDventures AB	SEK 0.14	-0.61×	0.11×	10.89×	-0.49×	-1015.0%	90.8%	-1797.3%	-1794.8%	-18.6%	-18.4%	-22.2%	0×	0.12×	0×	24.45×	0.0%	3	-2.69	2	B-
ALZCUR.STAlzeCure Pharma AB	SEK 6.46	-4.26×	6.11×	0×	-3.24×	-92.8%	0.0%	0.0%	0.0%	-144.8%	-139.1%	-17.2%	0.16×	0.94×	-180.85×	2.33×	0.0%	5	15.15	3	B+
ANNX.STAnnexin Pharmaceuticals AB	SEK 9.16	-3.55×	5.25×	0×	-2.81×	-42.7%	0.0%	0.0%	0.0%	-148.0%	-145.6%	-28.3%	0×	0.74×	0×	5.47×	0.0%	1	-32.9	1	C-
BIOWKS.STBio-Works Technologies AB (publ)	SEK 3.17	-15.41×	4.64×	3.66×	-11.76×	-1411.9%	76.5%	-28.0%	-24.4%	-31.0%	-31.6%	-8.4%	0×	2.12×	-90.77×	3.2×	0.0%	4	16.39	2	C
BOUL.STBoule Diagnostics AB	SEK 1.22	-49.1×	1.11×	0.38×	16.9×	-8578.3%	43.7%	0.9%	-0.8%	-2.3%	-0.7%	-2.2%	1.34×	8.83×	0.28×	1.09×	0.0%	3	0.3	2	C
ININIT.STInitiator Pharma A/S	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Peer median	—	-9.83×	4.95×	0.19×	-3.02×	-752.4%	21.8%	0.0%	-0.4%	-87.9%	-85.4%	-12.8%	0.08×	1.53×	-45.39×	2.77×	0.0%	4	7.72	2	—